How should I discontinue trazodone 200 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Discontinue Trazodone 200 mg

Gradually taper trazodone rather than stopping abruptly, reducing the dose slowly over weeks to months to minimize withdrawal symptoms. 1

Tapering Approach

The FDA label explicitly states that you should "gradually reduce the dosage rather than stopping Trazodone Hydrochloride Tablets abruptly whenever possible" 1. This is critical because abrupt discontinuation can trigger a discontinuation syndrome.

Expected Withdrawal Symptoms

If trazodone is stopped too quickly, patients may experience 1:

  • Nausea and sweating
  • Dysphoric mood, irritability, agitation
  • Dizziness and sensory disturbances (paresthesias, electric shock sensations)
  • Tremor, anxiety, confusion
  • Headache, lethargy, emotional lability
  • Insomnia, hypomania, tinnitus
  • Seizures (rare but possible)

Research confirms that trazodone withdrawal symptoms can develop even with gradual discontinuation, particularly because trazodone and its active metabolite (m-chlorophenylpiperazine) have short half-lives (3-9 hours), which increases rebound risk 2, 3.

Practical Tapering Schedule

Standard Risk Patients

For patients at lower risk of withdrawal (shorter duration of use, lower doses, no prior withdrawal difficulties):

  • Reduce by 25-50% every 2-4 weeks 4
  • Example for 200 mg daily:
    • Week 0-2: 150 mg daily
    • Week 2-4: 100 mg daily
    • Week 4-6: 50 mg daily
    • Week 6-8: 25 mg daily
    • Week 8+: Stop

High Risk Patients

For patients at higher risk (long-term use, higher doses, previous withdrawal difficulties, or concurrent psychiatric conditions):

  • Use hyperbolic (proportionate) dose reductions - reduce by 5-10% of the current dose every 2-4 weeks 5, 6
  • This means smaller absolute reductions as you approach lower doses
  • Example for 200 mg daily:
    • Weeks 0-2: 180 mg (10% reduction)
    • Weeks 2-4: 162 mg (10% reduction)
    • Weeks 4-6: 146 mg (10% reduction)
    • Continue this pattern, making progressively smaller absolute cuts
    • May need to taper down to very low doses (e.g., 10 mg, 5 mg, or even lower) before stopping entirely

The key principle: Hyperbolic tapering produces consistent pharmacological changes at the receptor level, while linear tapering produces escalating withdrawal effects as doses get lower 6.

Clinical Monitoring

  • Follow-up every 2-4 weeks during tapering 5
  • If withdrawal symptoms emerge:
    • Pause the taper or return to the previous tolerated dose
    • Wait until symptoms resolve before attempting further reduction
    • Slow the rate of taper (smaller decrements, longer intervals)
  • Differentiate withdrawal symptoms from depression relapse (withdrawal typically includes physical symptoms like dizziness and paresthesias)

Important Caveats

Do not confuse withdrawal with relapse: Withdrawal symptoms typically emerge within days of dose reduction and include prominent somatic symptoms, while depression relapse develops more gradually over weeks 7.

Very slow tapering may be necessary: Some patients, particularly those on trazodone for years, may require tapering over many months or even 1-2 years 2, 5. Research specifically notes that trazodone "should be tapered off at a very slow rate" due to its pharmacokinetic properties 2.

Formulation considerations: At very low doses, you may need liquid formulations or compounded preparations to achieve small enough dose reductions (e.g., reducing from 10 mg to 5 mg to 2.5 mg) 5, 4.

Context: Why Trazodone Should Be Discontinued

Guidelines actually recommend against using trazodone for chronic insomnia (its most common off-label use), as the evidence shows no differences in sleep efficiency compared to placebo, and its adverse effect profile outweighs limited benefits 8, 9. This makes successful discontinuation particularly important for patients using it off-label for sleep.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.